| |
Pfizer Inc and Subsidiary Companies
 |
|
|
|
|
|
|
|
|
|
|
|
|
| (millions of dollars) |
|
Health
Care
|
Animal
Health
|
Consumer
Health
Care |
Corporate/
Other |
Consolidated |
 |
| Total revenues |
1997 |
$ |
10,689(1) |
|
$1,329 |
|
$486 |
|
$ — |
|
$12,504(1) |
| |
1996 |
|
9,630 |
|
1,222 |
|
454 |
|
— |
|
11,306 |
| |
1995 |
|
8,409 |
|
1,219 |
|
393 |
|
— |
|
10,021 |
|
| Segment profit |
1997 |
|
3,309 |
|
112 |
|
39 |
|
(372)(2) |
|
3,088(3) |
| |
1996 |
|
3,090 |
|
101 |
|
36 |
|
(423)(2) |
|
2,804(3) |
| |
1995 |
|
2,548 |
|
97 |
|
36 |
|
(382)(2) |
|
2,299(3) |
|
| Identifiable assets(4) |
1997 |
|
7,058 |
|
2,196 |
|
483 |
|
5,599 |
|
15,336 |
| |
1996 |
|
6,686 |
|
2,243 |
|
473 |
|
5,265 |
|
14,667 |
| |
1995 |
|
5,557 |
|
2,069 |
|
307 |
|
4,796(5) |
|
12,729 |
|
| Property, plant and equipment additions(4) |
1997 |
|
734 |
|
69 |
|
18 |
|
122 |
|
943 |
| |
1996 |
|
594 |
|
87 |
|
22 |
|
71 |
|
774 |
| |
1995 |
|
515 |
|
74 |
|
28 |
|
79(5) |
|
696 |
|
| Depreciation and amortization(4) |
1997 |
|
393 |
|
75 |
|
18 |
|
16 |
|
502 |
| |
1996 |
|
319 |
|
82 |
|
15 |
|
14 |
|
430 |
| |
1995 |
|
271 |
|
57 |
|
12 |
|
34(5) |
|
374 |
|
(1)Includes alliance revenue of $316 million. |
(2)Includes interest income/(expense) and corporate expenses. Also includes other income/(expense) of the financial subsidiaries (see note 3, “Financial Subsidiaries”). |
(3)Consolidated total equals income from continuing operations before provision for taxes on income and minority interests. |
(4)Certain production facilities are shared by various segments. Property, plant and equipment, as well as capital additions and depreciation, are allocated based on physical production. Corporate assets are primarily cash, short-term investments and long-term marketable securities. |
(5)Includes amounts for the food science business which was sold in 1996. |
|
